sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
cgcctcggaatccaaggtgtagg | 1629 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
cgcctcggaatccaaggtgtagg | 1629 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 4443 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 4443 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 4443 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 3722 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 3722 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
ctaaaatagtttacacctatact | 3722 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 2434 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 2434 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 2434 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 3073 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 3073 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
gcctgccctcagggatcttgcat | 3073 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 4414 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 4414 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 4414 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 3803 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 3803 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
atgaacttgttggcccatctatt | 3803 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 2082 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 2082 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 2082 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 1814 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 1814 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 1814 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 2726 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 2726 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 2726 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcaccggtttggacttcatta | 2460 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 2460 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaccggtttggacttcatta | 2460 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 6239 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 6239 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 6239 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 5209 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 5209 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
tcaaccacattgttttgaaaata | 5209 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2306 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2306 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2306 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2882 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2882 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2882 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
taatcccagatgcagcccactct | 2616 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2616 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2616 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2038 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2038 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
taatcccagatgcagcccactct | 2038 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 4829 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 4829 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 4829 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 5619 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 5619 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 5619 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | null |
aaaaccaactgattcttgcttct | 5189 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaaaccaactgattcttgcttct | 5189 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaaaccaactgattcttgcttct | 5189 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaaaccaactgattcttgcttct | 5979 | EP4416284A1 | Extra-hepatic delivery irna compositions and methods of use thereof | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaaaccaactgattcttgcttct | 5979 | EP4416284A1 | EXTRAHEPATISCHE IRNA-ZUSAMMENSETZUNGEN ZUR ABGABE UND VERFAHREN ZUR VERWENDUNG DAVON | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
aaaaccaactgattcttgcttct | 5979 | EP4416284A1 | COMPOSITIONS D'ARNI À ADMINISTRATION EXTRA-HÉPATIQUE ET LEURS PROCÉDÉS D'UTILISATION | 20,240,821 | 1 | [
"JP",
"NZ",
"EA",
"SG",
"CN",
"MX",
"AU",
"IN",
"US",
"EP",
"WO",
"HK",
"IL",
"ZA",
"CA",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
guucaaguggauccacauuga | 62 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
guucaaguggauccacauuga | 246 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
guucaaguggauccacauuga | 146 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ccaguucaaguggauccacau | 243 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ccaguucaaguggauccacau | 71 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ccaguucaaguggauccacau | 143 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
aaguggauccacauugaggga | 150 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
aaguggauccacauugaggga | 250 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
aaguggauccacauugaggga | 30 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucagaucgaccuucucaaaguc | 277 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucagaucgaccuucucaaaguc | 177 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
acgcacaggaucugcuucucuuc | 41 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuugaacugggucagaucaaccu | 114 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuugaacugggucagaucaaccu | 291 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuugaacugggucagaucaaccu | 191 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ccugguggacaaguacccuaa | 83 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuggccacaucuuugcugacaaa | 218 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuggccacaucuuugcugacaaa | 40 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uuggccacaucuuugcugacaaa | 318 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gccugccagaugugucugcua | 61 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gccugccagaugugucugcua | 239 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gccugccagaugugucugcua | 139 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gauccugugcguggggcuagu | 137 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gauccugugcguggggcuagu | 237 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gauccugugcguggggcuagu | 78 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
cuuugagaaggucgaucugaa | 127 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
cuuugagaaggucgaucugaa | 227 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gguggacaaauacccagagga | 226 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
gguggacaaauacccagagga | 126 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucccucaauguggauccacuuga | 51 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucccucaauguggauccacuuga | 200 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
ucccucaauguggauccacuuga | 300 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uaauguggauccacuugaacugg | 96 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uaauguggauccacuugaacugg | 295 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uaauguggauccacuugaacugg | 195 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucaaguggauccacauugaa | 65 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucaaguggauccacauugaa | 147 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
uucaaguggauccacauugaa | 247 | US20220127618A1 | KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,220,428 | 17 | [
"JP",
"CN",
"US",
"EA",
"AU",
"KR",
"WO",
"DE",
"EP",
"CA",
"HK",
"AT",
"NZ"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.